Cargando…

Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set

The increase of publicly available bioactivity data in recent years has fueled and catalyzed research in chemogenomics, data mining, and modeling approaches. As a direct result, over the past few years a multitude of different methods have been reported and evaluated, such as target fishing, nearest...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenselink, Eelke B., ten Dijke, Niels, Bongers, Brandon, Papadatos, George, van Vlijmen, Herman W. T., Kowalczyk, Wojtek, IJzerman, Adriaan P., van Westen, Gerard J. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555960/
https://www.ncbi.nlm.nih.gov/pubmed/29086168
http://dx.doi.org/10.1186/s13321-017-0232-0
_version_ 1783256977254645760
author Lenselink, Eelke B.
ten Dijke, Niels
Bongers, Brandon
Papadatos, George
van Vlijmen, Herman W. T.
Kowalczyk, Wojtek
IJzerman, Adriaan P.
van Westen, Gerard J. P.
author_facet Lenselink, Eelke B.
ten Dijke, Niels
Bongers, Brandon
Papadatos, George
van Vlijmen, Herman W. T.
Kowalczyk, Wojtek
IJzerman, Adriaan P.
van Westen, Gerard J. P.
author_sort Lenselink, Eelke B.
collection PubMed
description The increase of publicly available bioactivity data in recent years has fueled and catalyzed research in chemogenomics, data mining, and modeling approaches. As a direct result, over the past few years a multitude of different methods have been reported and evaluated, such as target fishing, nearest neighbor similarity-based methods, and Quantitative Structure Activity Relationship (QSAR)-based protocols. However, such studies are typically conducted on different datasets, using different validation strategies, and different metrics. In this study, different methods were compared using one single standardized dataset obtained from ChEMBL, which is made available to the public, using standardized metrics (BEDROC and Matthews Correlation Coefficient). Specifically, the performance of Naïve Bayes, Random Forests, Support Vector Machines, Logistic Regression, and Deep Neural Networks was assessed using QSAR and proteochemometric (PCM) methods. All methods were validated using both a random split validation and a temporal validation, with the latter being a more realistic benchmark of expected prospective execution. Deep Neural Networks are the top performing classifiers, highlighting the added value of Deep Neural Networks over other more conventional methods. Moreover, the best method (‘DNN_PCM’) performed significantly better at almost one standard deviation higher than the mean performance. Furthermore, Multi-task and PCM implementations were shown to improve performance over single task Deep Neural Networks. Conversely, target prediction performed almost two standard deviations under the mean performance. Random Forests, Support Vector Machines, and Logistic Regression performed around mean performance. Finally, using an ensemble of DNNs, alongside additional tuning, enhanced the relative performance by another 27% (compared with unoptimized ‘DNN_PCM’). Here, a standardized set to test and evaluate different machine learning algorithms in the context of multi-task learning is offered by providing the data and the protocols. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-017-0232-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5555960
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-55559602017-08-29 Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set Lenselink, Eelke B. ten Dijke, Niels Bongers, Brandon Papadatos, George van Vlijmen, Herman W. T. Kowalczyk, Wojtek IJzerman, Adriaan P. van Westen, Gerard J. P. J Cheminform Research Article The increase of publicly available bioactivity data in recent years has fueled and catalyzed research in chemogenomics, data mining, and modeling approaches. As a direct result, over the past few years a multitude of different methods have been reported and evaluated, such as target fishing, nearest neighbor similarity-based methods, and Quantitative Structure Activity Relationship (QSAR)-based protocols. However, such studies are typically conducted on different datasets, using different validation strategies, and different metrics. In this study, different methods were compared using one single standardized dataset obtained from ChEMBL, which is made available to the public, using standardized metrics (BEDROC and Matthews Correlation Coefficient). Specifically, the performance of Naïve Bayes, Random Forests, Support Vector Machines, Logistic Regression, and Deep Neural Networks was assessed using QSAR and proteochemometric (PCM) methods. All methods were validated using both a random split validation and a temporal validation, with the latter being a more realistic benchmark of expected prospective execution. Deep Neural Networks are the top performing classifiers, highlighting the added value of Deep Neural Networks over other more conventional methods. Moreover, the best method (‘DNN_PCM’) performed significantly better at almost one standard deviation higher than the mean performance. Furthermore, Multi-task and PCM implementations were shown to improve performance over single task Deep Neural Networks. Conversely, target prediction performed almost two standard deviations under the mean performance. Random Forests, Support Vector Machines, and Logistic Regression performed around mean performance. Finally, using an ensemble of DNNs, alongside additional tuning, enhanced the relative performance by another 27% (compared with unoptimized ‘DNN_PCM’). Here, a standardized set to test and evaluate different machine learning algorithms in the context of multi-task learning is offered by providing the data and the protocols. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-017-0232-0) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-08-14 /pmc/articles/PMC5555960/ /pubmed/29086168 http://dx.doi.org/10.1186/s13321-017-0232-0 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lenselink, Eelke B.
ten Dijke, Niels
Bongers, Brandon
Papadatos, George
van Vlijmen, Herman W. T.
Kowalczyk, Wojtek
IJzerman, Adriaan P.
van Westen, Gerard J. P.
Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
title Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
title_full Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
title_fullStr Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
title_full_unstemmed Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
title_short Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
title_sort beyond the hype: deep neural networks outperform established methods using a chembl bioactivity benchmark set
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555960/
https://www.ncbi.nlm.nih.gov/pubmed/29086168
http://dx.doi.org/10.1186/s13321-017-0232-0
work_keys_str_mv AT lenselinkeelkeb beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset
AT tendijkeniels beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset
AT bongersbrandon beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset
AT papadatosgeorge beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset
AT vanvlijmenhermanwt beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset
AT kowalczykwojtek beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset
AT ijzermanadriaanp beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset
AT vanwestengerardjp beyondthehypedeepneuralnetworksoutperformestablishedmethodsusingachemblbioactivitybenchmarkset